FDA Approves Benlysta (belimumab) Autoinjector for Children with Active Lupus Nephritis

Jun 25, 2025 - 02:00
 0  0
FDA Approves Benlysta (belimumab) Autoinjector for Children with Active Lupus Nephritis
Philadelphia, PA June 24 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector of Benlysta (belimumab), a B-lymphocyte stimulator (BlyS)-specific inhibiting monoclonal...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0